Prediction of Human Induced Pluripotent Stem Cell Cardiac Differentiation Outcome by Multifactorial Process Modeling

Human cardiomyocytes (CMs) have potential for use in therapeutic cell therapy and high-throughput drug screening. Because of the inability to expand adult CMs, their large-scale production from human pluripotent stem cells (hPSC) has been suggested. Significant improvements have been made in underst...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Bianca, Löbel, Wiebke, Finklea, Ferdous, Halloin, Caroline, Ritzenhoff, Katharina, Manstein, Felix, Mohammadi, Samira, Hashemi, Mohammadjafar, Zweigerdt, Robert, Lipke, Elizabeth, Cremaschi, Selen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390976/
https://www.ncbi.nlm.nih.gov/pubmed/32793579
http://dx.doi.org/10.3389/fbioe.2020.00851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390976/
https://www.ncbi.nlm.nih.gov/pubmed/32793579
http://dx.doi.org/10.3389/fbioe.2020.00851

Ejemplares similares